B. Fırlatan Et Al. , "Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly," Hormones , 2024
Fırlatan, B. Et Al. 2024. Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly. Hormones .
Fırlatan, B., Karakulak, U. N., Hekimsoy, V., Iremli, B. G., Lay, İ., Yüce, D., ... Dağdelen, S.(2024). Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly. Hormones .
Fırlatan, BÜŞRA Et Al. "Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly," Hormones , 2024
Fırlatan, BÜŞRA Et Al. "Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly." Hormones , 2024
Fırlatan, B. Et Al. (2024) . "Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly." Hormones .
@article{article, author={BÜŞRA FIRLATAN Et Al. }, title={Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly}, journal={Hormones}, year=2024}